ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nuveen Asset Management, LLC | 292,022 | $592,804 | 0.00% |
| PATHSTONE FAMILY OFFICE, LLC | 10,000 | $20,300 | 0.00% |
| Caption Management, LLC | 2,671 | $5,422 | 0.00% |
| Steward Partners Investment Advisory, LLC | 4,000 | $8,120 | 0.00% |
| Qube Research & Technologies Ltd | 8,212 | $16,670 | 0.00% |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% |
| SIMPLEX TRADING, LLC | 25,391 | $51 | 0.00% |
| CWM, LLC | 10 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 119,000 | $241,570 | 0.00% |
| AQR Capital Management | 40,598 | $82,414 | 0.00% |
| BARCLAYS PLC | 131,845 | $268 | 0.00% |
| ROYAL BANK OF CANADA | 116,174 | $236,000 | 0.00% |
| VANGUARD GROUP INC | 5,948,022 | $12,074,485 | 0.00% |
| VICTORY CAPITAL MANAGEMENT INC | 13,810 | $28,034 | 0.00% |
| VOYA INVESTMENT MANAGEMENT LLC | 138,971 | $282,111 | 0.00% |
| CAMBRIDGE TRUST CO | 5,000 | $10,150 | 0.00% |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 27,541 | $55,908 | 0.00% |
| UBS Group AG | 62,618 | $127,115 | 0.00% |
| ALLIANCEBERNSTEIN L.P. | 91,100 | $184,933 | 0.00% |
| RHUMBLINE ADVISERS | 168,232 | $341,501 | 0.00% |
External links
This page lists ARBUTUS BIOPHARMA CORP's shareholders in Q3 2023. To view ARBUTUS BIOPHARMA CORP's shareholder history, click here.